Product Information
DESIPRAMINE 25 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1269 per EA under NDC 62332031631. Its NADAC has been published 262 times since Sep 29, 2021.
FDA first approved this application on Jul 7, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332031631
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209785FDA Approved
7/7/2021
TE Code
AB
On Market Since
7/8/2021
Pharmacological Classes
Price Statistics
The NADAC for DESIPRAMINE 25 MG TABLET has been published 262 times since Sep 29, 2021, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1269 per EA |
|---|---|
| All-time high | $0.4119 (Apr 13, 2022) |
| All-time low | $0.1179 (Feb 21, 2024) |
| 52-week high | $0.1718 |
| 52-week low | $0.1269 |
| Median price | $0.1805 |
| Average price | $0.2003 |
| Largest weekly change | +101.6% (Mar 20, 2024) |
| Weeks tracked | 262 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DESIPRAMINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DESIPRAMINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESIPRAMINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESIPRAMINE 25 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1269 per EA (NDC 62332031631), effective Sep 30, 2026.
How has the price of DESIPRAMINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESIPRAMINE 25 MG TABLET has declined 54.7%. It has been tracked across 262 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for DESIPRAMINE 25 MG TABLET?
Since Sep 29, 2021, the NADAC for DESIPRAMINE 25 MG TABLET has ranged from a low of $0.1179 (Feb 21, 2024) to a high of $0.4119 (Apr 13, 2022), with a median of $0.1805 per EA.
Are there cheaper alternatives to DESIPRAMINE 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DESIPRAMINE 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESIPRAMINE 25 MG TABLET?
DESIPRAMINE 25 MG TABLET (NDC 62332031631) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.